证券研究报告 | 公司动态点评 2024 年 09 月 09 日 锦浪科技（300763.SZ） 逆变器主业改善显著，电站业务资产稳健 | --- | --- | --- | --- | --- | --- | --- | --- | |---------------------------------------------|---------------|-------------|--------------|--------------|------------|-----------------------------------------|------------------| | 财务指标 | 2022A | 2023A | 2024E | 2025E | 2026E | 增持（维持评级） | | | | | | | | | | | | | | | | | | | | | 营业收入（百万元） | 5,890 | 6,101 | 8,886 | 11,295 | 13,497 | 股票信息 | | | 增长率 yoy （ % ） | 77.8 | 3.6 | 45.7 | 27.1 | 19.5 ...

证券研究报告 | 行业周报 2024 年 09 月 10 日 电力设备及新能源 优化能源结构发展，推动氢能科技协同发展 行情回顾：截至 2024 年 9 月 6 日，氢能源指数收盘价为 1346.31 点，本 周涨跌幅为-2.35%，2024 年初至今涨跌幅为-22.69%。氢能行业周涨幅 前五的公司为南都电源、科恒股份、德尔股份、动力新科、曼恩斯特，涨 幅分别为 66.93% 、21.24% 、15.68% 、10.66% 、9.79% ；氢能行 业周跌幅前五的公司为光智科技、恒华科技、卫星化学、ST 墨龙、富瑞 特装，跌幅分别为-10.99% 、-9.37% 、-8.98% 、-8.96% 、-8.96% 。 重点事件点评：国际首例跨洋液氢运输工程启动，中国—东盟氢能产业基 地在广西百色揭牌，国内首条按城镇燃气工程申报的城镇氢气输送管道获 建设许可，阿布扎比国家石油公司和埃克森美孚共建世界最大低碳氢工 厂，中方助力非洲国家优化能源结构和产业结构发展，苏黎世联邦理工学 院研究出铁储氢技术，国务院发布《中国的能源转型》白皮书，国家发改 委等十部门联合发布《数字化绿色化协同转型发展实施指南》，内蒙发布 风光制氨 ...

证券研究报告|公司动态点评 2024 年 09 月 10 日 龙佰集团（002601.SZ） 钛白粉量价齐升推动业绩增长，看好公司上游钛矿布局及钪钒新材 料项目 | --- | --- | --- | --- | --- | --- | |----------------------|--------|--------|--------|--------|--------| | 财务指标 | 2022A | 2023A | 2024E | 2025E | 2026E | | 营业收入（百万元） | 24,113 | 26,765 | 29,913 | 33,856 | 37,558 | | 增长率 yoy （ % ） | 17.2 | 11.0 | 11.8 | 13.2 | 10.9 | | 归母净利润（百万元） | 3,419 | 3,226 | 3,483 | 4,326 | 5,141 | | 增长率 yoy （ % ） | -26.9 | -5.6 | 8.0 | 24.2 | 18.8 | | ROE （ % ） | 15.2 | 13.0 | 12.4 | 13.3 | 13.7 | | EPS ...

证券研究报告 | 行业周报 2024 年 09 月 10 日 电力设备及新能源 优化能源结构发展，推动氢能科技协同发展 行情回顾：截至 2024 年 9 月 6 日，氢能源指数收盘价为 1346.31 点，本 周涨跌幅为-2.35%，2024 年初至今涨跌幅为-22.69%。氢能行业周涨幅 前五的公司为南都电源、科恒股份、德尔股份、动力新科、曼恩斯特，涨 幅分别为 66.93% 、21.24% 、15.68% 、10.66% 、9.79% ；氢能行 业周跌幅前五的公司为光智科技、恒华科技、卫星化学、ST 墨龙、富瑞 特装，跌幅分别为-10.99% 、-9.37% 、-8.98% 、-8.96% 、-8.96% 。 重点事件点评：国际首例跨洋液氢运输工程启动，中国—东盟氢能产业基 地在广西百色揭牌，国内首条按城镇燃气工程申报的城镇氢气输送管道获 建设许可，阿布扎比国家石油公司和埃克森美孚共建世界最大低碳氢工 厂，中方助力非洲国家优化能源结构和产业结构发展，苏黎世联邦理工学 院研究出铁储氢技术，国务院发布《中国的能源转型》白皮书，国家发改 委等十部门联合发布《数字化绿色化协同转型发展实施指南》，内蒙发布 风光制氨 ...

Investment Rating - The report maintains an "Accumulate" rating for the company [1][10][17] Core Views - The company's performance is under short-term pressure, but there is optimism regarding the formation of China Salt Lake Group, which is expected to enhance the integration and high-quality development of domestic salt lake resources [3][10] Financial Summary - **Revenue (in million CNY)**: - 2022A: 30,739 - 2023A: 21,579 - 2024E: 15,053 - 2025E: 16,466 - 2026E: 19,414 - YoY Growth Rates: 108.0%, -29.8%, -30.2%, 9.4%, 17.9% [1][11] - **Net Profit (in million CNY)**: - 2022A: 15,568 - 2023A: 7,914 - 2024E: 4,964 - 2025E: 5,832 - 2026E: 7,253 - YoY Growth Rates: 247.6%, -49.2%, -37.3%, 17.5%, 24.4% [1][11] - **Key Financial Ratios**: - ROE: 69.0% (2022A), 27.0% (2023A), 14.5% (2024E), 14.5% (2025E), 15.3% (2026E) [1][11] - EPS: 2.87 (2022A), 1.46 (2023A), 0.91 (2024E), 1.07 (2025E), 1.34 (2026E) [1][11] - P/E: 5.2 (2022A), 10.2 (2023A), 16.2 (2024E), 13.8 (2025E), 11.1 (2026E) [1][11] - P/B: 3.2 (2022A), 2.5 (2023A), 2.2 (2024E), 1.9 (2025E), 1.6 (2026E) [1][11] Operational Insights - The company's main products, potassium chloride and lithium carbonate, experienced a decline in revenue due to price drops, with potassium chloride revenue at 5.338 billion CNY (down 14.29% YoY) and lithium carbonate revenue at 1.683 billion CNY (down 49.81% YoY) [3][4] - The average selling price of lithium carbonate fell significantly by 62.81% YoY, with a reported average price of 93,949.58 CNY/ton in 1H24 [3][4] Strategic Developments - The company is progressing well with a new 40,000-ton lithium salt project, expected to enhance its competitive edge in lithium extraction [9] - A strategic cooperation agreement was signed with China Minmetals, which is anticipated to strengthen the company's shareholder background and facilitate the formation of China Salt Lake Group [9][10]

Investment Rating - The report maintains a "Buy" rating for the company, expecting a price increase of over 15% relative to the industry index within the next six months [8]. Core Views - The company is projected to achieve a net profit attributable to shareholders of approximately 411 to 426 million yuan for the first three quarters of 2024, representing a year-on-year increase of 43.29% to 48.52% [2]. - The company has actively repurchased shares, acquiring 2.12% of its total shares from August 13 to September 6, with a total expenditure of 204 million yuan, reflecting strong operational confidence [2]. - The core products, including Wuling Capsules and Lingze Tablets, continue to show robust growth, with significant sales increases driven by strategic marketing and product positioning [2]. Financial Summary - For 2024, the company expects to generate revenue of 2.466 billion yuan, with a year-on-year growth rate of 26.9% [3]. - The projected net profit for 2024 is estimated at 528 million yuan, reflecting a year-on-year growth of 37.8% [3]. - The company's return on equity (ROE) is expected to rise to 18.0% in 2024, indicating improved profitability [3]. - The earnings per share (EPS) is projected to reach 0.75 yuan in 2024, with a continuous upward trend in subsequent years [3]. Product and Market Strategy - The company is focusing on expanding its hospital coverage and enhancing its presence in the OTC market, utilizing a marketing strategy aimed at consumer education and product application [2]. - The Wuling Capsule, recognized as a national first-class new drug, has been recommended in 69 clinical pathways and guidelines, showcasing its established market position [2]. - The company is also developing a scientific and effective incentive plan for its employees, which is expected to further enhance operational performance [2].

证券研究报告 强大于市 政策叠加高基数行业短期承压，降本增效显著 长城证券产业金融研究院 分析师：刘鹏 执业证书编号：S1070520030002 邮箱：liupeng@cgws.com 联系人：袁紫馨 执业证书编号：S1070122080041 邮箱：yuanzixin@cgws.com ——中药行业8月月报和9月观点 2024年9月1日 9月中药板块投资策略 www.cgws.com 中报总结：H1行业整体受高基数影响承压，全年业绩有望修复 中药板块2024H1实现营收1819亿元（yoy-3.32%），实现归母净利润221亿元（yoy-8.96%），高基数下板块整体有所 承压。2023H1营收和归母净利润占全年比重均有不同程度提升，我们假设2024H1营收和归母净利润比重分别为50%和 60%，预测2024年营收和归母净利润分别同比增长1.56%和1.43%，全年业绩有望逐步修复。 2017-2024H1中药板块营业收入及增速 2017-2024H1中药板块归母净利润及增速 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 40% 3,162 3,070 3 ...

证券研究报告|行业周报 2024 年 09 月 10 日 电力及公用事业 行业周报（9.2-9.6）：绿证核发和交易规则出台，板块指数表现持 续回落 | --- | --- | --- | --- | --- | --- | --- | --- | --- | |---------------|----------------------------------|---------------|---------------|------------------|------------|-------|-------|---------------------------------------| | 股票 \n代码 | 股票 \n名称 | 投资 \n评级 | EPS \n2024E | （元） \n2025E | PE \n2024E | 2025E | | 强于大市（维持评级） | | 600163.SH | 中闽能源 | 增持 | 0.41 | 0.42 | 10.59 | 10.33 | | 行业走势 | | 600674.SH | 川投能源 | 增持 | 1.03 | 1.1 | 17.22 | ...

Investment Rating - The report maintains a rating of "Accumulate" for the company [1][5]. Core Views - The company's short-term performance is under pressure, but the future outlook remains promising due to the growth potential in the wind power industry [2][5]. - The company reported a significant decline in net profit for H1 2024, but there are expectations for a recovery in profitability in the second half of the year [2][5]. Financial Summary - **Revenue (Million CNY)**: - 2022A: 1,812 - 2023A: 1,946 - 2024E: 2,191 - 2025E: 2,931 - 2026E: 3,782 - Growth Rate (YoY %): 2024E: 12.6%, 2025E: 33.8%, 2026E: 29.0% [1][6][8] - **Net Profit (Million CNY)**: - 2022A: 352 - 2023A: 412 - 2024E: 363 - 2025E: 564 - 2026E: 731 - Growth Rate (YoY %): 2024E: -12.0%, 2025E: 55.6%, 2026E: 29.6% [1][6][8] - **EPS (CNY)**: - 2022A: 1.10 - 2023A: 1.29 - 2024E: 1.13 - 2025E: 1.76 - 2026E: 2.28 [1][6][8] Industry Insights - The wind power industry is expected to see significant growth, with a projected increase of 791 GW in global wind power capacity over the next five years [2]. - The company is strategically positioned to benefit from this growth, particularly in its forging and casting segments, which are expected to see increased demand [2][5]. Business Development - The company has successfully developed new clients and achieved a revenue increase of over 40% in precision shaft products, indicating a potential second growth curve [5]. - The company is expanding its capabilities in both forging and casting, with significant orders from major players in the wind power sector [2][5]. Future Projections - Revenue projections for 2024-2026 are as follows: - 2024: 2,191 million CNY - 2025: 2,931 million CNY - 2026: 3,782 million CNY - Net profit projections for the same period are: - 2024: 363 million CNY - 2025: 564 million CNY - 2026: 731 million CNY [5][6].

证券研究报告 | 公司动态点评 2024 年 09 月 10 日 华鲁恒升（600426.SH） 荆州一期贡献增量，收入利润双增，看好荆州二期项目建设 | --- | --- | --- | --- | --- | --- | --- | --- | |--------------------------------------------|--------|--------|--------|--------|--------|-----------------------------------------|-----------| | 财务指标 | 2022A | 2023A | 2024E | 2025E | 2026E | 买入（维持评级） | | | 营业收入（百万元） | 30,245 | 27,260 | 34,184 | 38,418 | 42,353 | 股票信息 | | | 增长率 yoy （ % ） | 13.1 | -9.9 | 25.4 | 12.4 | 10.2 | | | | 归母净利润（百万元） | 6,289 | 3,576 | 4,629 | 5,657 | 6,730 ...